Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Soliris for neuromyelitis optica spectrum disorder

Aug. 28, 2019

FDA approves Nourianz for Parkinson's disease

Aug. 28, 2019

Genisphere collaborates with University Hospitals in pancreatic cancer

Aug. 28, 2019

Kintai Therapeutics announces academic collaborations in cancer

Aug. 28, 2019

IRLAB to prioritize L-dopa-induced dyskinesia indication in development of IRL-790

Aug. 28, 2019

Bristol-Myers Squibb presents discovery of lupus candidate BMS-615

Aug. 28, 2019

Boehringer Ingelheim describes new ghrelin O-acyltransferase inhibitors

Aug. 28, 2019

New polycomb protein EED inhibitors identified at Mirati Therapeutics

Aug. 28, 2019

Lilly discovers TRPA1 antagonists

Aug. 28, 2019

Asahikawa Medical University, Hokkaido University patent echinomycin derivatives

Aug. 28, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...